Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to boost mental strength in hospitalized teens with cancer

NCT ID NCT07228533

Symptom relief Sponsor: Eskisehir Osmangazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test a new mobile app called CesiKids, designed by nurses, recovered teens, and parents, to help adolescents aged 12-18 with cancer build psychological resilience while in the hospital. The app uses AI to adapt to each teen's needs and includes activities to strengthen coping skills. Thirty-six teens will be randomly assigned to use the app for four weeks or receive standard care, and researchers will measure changes in resilience and coping at several points. This is an early-stage trial to see if the approach is helpful and feasible.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CesiKids mobile-based psychological resilience program (nurse-led, AI-supported mobile application)
What this could lead to
If it works, this could offer a new, scalable way to help hospitalized teens with cancer feel stronger emotionally and cope better during treatment.
What could go wrong
This is a very small early trial (36 participants) testing a new app, so results may not apply to all teens. The program is still being developed and may not show clear benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2025

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Parents have provided informed consent after receiving information, * The child has given assent to participate after being informed, * The child is between 12 and 18 years of age, * The child has been diagnosed with cancer and is currently receiving inpatient treatment, * The child is undergoing chemotherapy and/or radiotherapy, * The child is able to use a computer and/or smartphone, * The child can understand and speak Turkish. Exclusion Criteria: * Receiving hematopoietic stem cell transplantation treatment, * Having developed a relapse after remission, * Experiencing communication difficulties (e.g., intellectual disability, visual impairment, etc.), * Having a psychiatric diagnosis made by a psychiatrist, * Having experienced a significant life event affecting psychological well-being within the past four weeks (e.g., death, divorce, etc.).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent cancer COPING Mobile application Pediatric cancer Pediatric nursing Resilience, psychological

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ankara University Faculty of Medicine Cebeci Research and Practice Hospital

    Ankara, Ankara, 06620, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.